- Home
- TARS vs VCYT Comparison
TARS vs VCYT Comparison
Compare TARS & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | VCYT |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TARS | VCYT |
|---|---|---|
| Price | $75.30 | $36.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $80.56 | $46.50 |
| AVG Volume (30 Days) | 616.6K | ★ 767.0K |
| Earning Date | 06-01-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.21 | ★ 164.52 |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $51.34 | $11.95 |
| Revenue Next Year | $29.34 | $11.97 |
| P/E Ratio | ★ N/A | $121.78 |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $38.51 | $22.61 |
| 52 Week High | $85.25 | $50.71 |
Technical Indicators
Market Signals| Indicator | TARS | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 45.20 |
| Support Level | $65.62 | $32.51 |
| Resistance Level | $76.81 | $37.24 |
| Average True Range (ATR) | 3.86 | 1.53 |
| MACD | 1.80 | 0.34 |
| Stochastic Oscillator | 75.85 | 40.63 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.